| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 6 | 2025 | 248 | 2.070 |
Why?
|
| Hepatoblastoma | 7 | 2024 | 183 | 1.910 |
Why?
|
| Liver Neoplasms | 9 | 2024 | 1408 | 1.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2025 | 2125 | 1.100 |
Why?
|
| MicroRNAs | 11 | 2025 | 945 | 1.000 |
Why?
|
| Gene Expression Profiling | 13 | 2023 | 1914 | 0.910 |
Why?
|
| Computational Biology | 9 | 2024 | 887 | 0.720 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2023 | 1001 | 0.680 |
Why?
|
| Transcriptome | 3 | 2023 | 1135 | 0.630 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 963 | 0.540 |
Why?
|
| Gene Regulatory Networks | 6 | 2018 | 398 | 0.520 |
Why?
|
| Neoplasms | 6 | 2024 | 2984 | 0.520 |
Why?
|
| RNA, Messenger | 8 | 2025 | 2876 | 0.490 |
Why?
|
| Neuroblastoma | 4 | 2022 | 550 | 0.480 |
Why?
|
| Receptor, Notch1 | 2 | 2015 | 79 | 0.470 |
Why?
|
| Glioblastoma | 3 | 2018 | 371 | 0.460 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2015 | 63 | 0.460 |
Why?
|
| Cell Line, Tumor | 18 | 2025 | 3794 | 0.460 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2025 | 19 | 0.450 |
Why?
|
| Algorithms | 11 | 2015 | 1730 | 0.440 |
Why?
|
| Transcription Factors | 10 | 2019 | 2719 | 0.420 |
Why?
|
| Homeodomain Proteins | 2 | 2015 | 584 | 0.380 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 571 | 0.380 |
Why?
|
| Humans | 65 | 2025 | 133271 | 0.360 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 1420 | 0.360 |
Why?
|
| Sequence Analysis, RNA | 5 | 2023 | 424 | 0.360 |
Why?
|
| Sequence Alignment | 3 | 2015 | 631 | 0.350 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 357 | 0.340 |
Why?
|
| Radiation Tolerance | 3 | 2025 | 66 | 0.310 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2023 | 97 | 0.310 |
Why?
|
| Cytokines | 2 | 2025 | 1378 | 0.300 |
Why?
|
| Oncogenes | 3 | 2018 | 181 | 0.290 |
Why?
|
| Cell Line | 8 | 2021 | 2855 | 0.290 |
Why?
|
| Cell Differentiation | 4 | 2025 | 2026 | 0.290 |
Why?
|
| Animals | 33 | 2025 | 36195 | 0.280 |
Why?
|
| Mice | 24 | 2025 | 18929 | 0.280 |
Why?
|
| Sequence Analysis, DNA | 6 | 2022 | 1830 | 0.280 |
Why?
|
| Sequence Analysis, Protein | 2 | 2004 | 49 | 0.280 |
Why?
|
| Binding Sites | 7 | 2014 | 1378 | 0.270 |
Why?
|
| Mutation | 8 | 2023 | 6341 | 0.270 |
Why?
|
| T-Lymphocytes | 6 | 2024 | 1770 | 0.250 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2018 | 196 | 0.250 |
Why?
|
| Ribonuclease III | 2 | 2025 | 103 | 0.250 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2025 | 150 | 0.240 |
Why?
|
| RNA, Neoplasm | 2 | 2018 | 146 | 0.240 |
Why?
|
| Genome, Human | 3 | 2021 | 1339 | 0.240 |
Why?
|
| Acrylamides | 1 | 2025 | 25 | 0.240 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2025 | 21 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 1067 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2025 | 1013 | 0.230 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2022 | 65 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2021 | 624 | 0.220 |
Why?
|
| Glypicans | 1 | 2024 | 39 | 0.220 |
Why?
|
| Receptors, Ghrelin | 1 | 2024 | 29 | 0.220 |
Why?
|
| Wound Healing | 2 | 2025 | 483 | 0.220 |
Why?
|
| Urinary Catheterization | 1 | 2024 | 87 | 0.220 |
Why?
|
| Interleukin-15 | 1 | 2024 | 96 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2025 | 151 | 0.210 |
Why?
|
| Separase | 2 | 2014 | 29 | 0.210 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 92 | 0.210 |
Why?
|
| Germinal Center | 4 | 2013 | 38 | 0.210 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2015 | 250 | 0.210 |
Why?
|
| Immunophenotyping | 1 | 2024 | 345 | 0.210 |
Why?
|
| RNA, Untranslated | 2 | 2021 | 120 | 0.210 |
Why?
|
| Cell Survival | 6 | 2025 | 884 | 0.210 |
Why?
|
| Piperidines | 1 | 2025 | 241 | 0.200 |
Why?
|
| Rats, Wistar | 1 | 2024 | 398 | 0.200 |
Why?
|
| DNA-Binding Proteins | 4 | 2019 | 2144 | 0.200 |
Why?
|
| Catheter-Related Infections | 1 | 2024 | 139 | 0.200 |
Why?
|
| Protons | 2 | 2021 | 98 | 0.200 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 241 | 0.190 |
Why?
|
| Sex Characteristics | 1 | 2024 | 334 | 0.190 |
Why?
|
| Signal Transduction | 7 | 2025 | 4915 | 0.190 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 77 | 0.190 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 4755 | 0.180 |
Why?
|
| Prognosis | 7 | 2024 | 5042 | 0.180 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2021 | 9 | 0.180 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2021 | 18 | 0.180 |
Why?
|
| RNA Interference | 2 | 2014 | 546 | 0.180 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 720 | 0.170 |
Why?
|
| Oxadiazoles | 1 | 2021 | 25 | 0.170 |
Why?
|
| Consensus Sequence | 2 | 2015 | 59 | 0.170 |
Why?
|
| Cell Death | 2 | 2019 | 248 | 0.170 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2024 | 899 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 297 | 0.170 |
Why?
|
| B-Lymphocytes | 4 | 2013 | 542 | 0.170 |
Why?
|
| Clonal Evolution | 1 | 2020 | 49 | 0.170 |
Why?
|
| Urinary Tract Infections | 1 | 2024 | 314 | 0.170 |
Why?
|
| Amish | 1 | 2020 | 11 | 0.160 |
Why?
|
| Atovaquone | 1 | 2019 | 10 | 0.160 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 399 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1558 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2022 | 367 | 0.160 |
Why?
|
| Linear Energy Transfer | 1 | 2019 | 9 | 0.160 |
Why?
|
| Compulsive Behavior | 1 | 2019 | 41 | 0.160 |
Why?
|
| Base Sequence | 5 | 2018 | 3153 | 0.160 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 38 | 0.160 |
Why?
|
| Genes, BRCA1 | 1 | 2019 | 61 | 0.150 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 591 | 0.150 |
Why?
|
| Photons | 1 | 2019 | 53 | 0.150 |
Why?
|
| Homologous Recombination | 1 | 2019 | 100 | 0.150 |
Why?
|
| Vaccination | 1 | 2024 | 1018 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 126 | 0.150 |
Why?
|
| Piperazines | 1 | 2021 | 256 | 0.150 |
Why?
|
| AIDS Dementia Complex | 1 | 2019 | 22 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2022 | 231 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2019 | 48 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2023 | 504 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 739 | 0.150 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 131 | 0.150 |
Why?
|
| Fetal Hemoglobin | 1 | 2018 | 28 | 0.150 |
Why?
|
| HIV Infections | 2 | 2022 | 2061 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2021 | 361 | 0.140 |
Why?
|
| Erythroid Cells | 1 | 2018 | 24 | 0.140 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2018 | 31 | 0.140 |
Why?
|
| Encephalitis | 1 | 2019 | 122 | 0.140 |
Why?
|
| Receptor, EphA2 | 1 | 2018 | 29 | 0.140 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2018 | 20 | 0.140 |
Why?
|
| Antigenic Variation | 1 | 2018 | 42 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2017 | 60 | 0.140 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 45 | 0.140 |
Why?
|
| Male | 21 | 2025 | 65523 | 0.140 |
Why?
|
| Child | 7 | 2024 | 25851 | 0.140 |
Why?
|
| Atazanavir Sulfate | 1 | 2017 | 6 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 317 | 0.140 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 767 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 335 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 216 | 0.130 |
Why?
|
| Microbiota | 1 | 2022 | 442 | 0.130 |
Why?
|
| Liver | 8 | 2021 | 1859 | 0.130 |
Why?
|
| Tyrosinemias | 1 | 2016 | 7 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2019 | 252 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 702 | 0.130 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2017 | 138 | 0.130 |
Why?
|
| Rats, Transgenic | 3 | 2022 | 15 | 0.130 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2650 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 259 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 788 | 0.130 |
Why?
|
| Quinazolines | 1 | 2017 | 185 | 0.130 |
Why?
|
| Metformin | 1 | 2018 | 166 | 0.120 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 1036 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2021 | 910 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2019 | 417 | 0.120 |
Why?
|
| Genomics | 3 | 2018 | 1677 | 0.120 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2015 | 21 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2003 | 1596 | 0.120 |
Why?
|
| Models, Biological | 3 | 2018 | 1530 | 0.120 |
Why?
|
| Female | 19 | 2024 | 71439 | 0.120 |
Why?
|
| Nanog Homeobox Protein | 1 | 2015 | 30 | 0.120 |
Why?
|
| HIV-1 | 1 | 2019 | 488 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 625 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 818 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2014 | 103 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 80 | 0.110 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 562 | 0.110 |
Why?
|
| Apoptosis | 5 | 2021 | 1928 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1310 | 0.110 |
Why?
|
| Gene Editing | 1 | 2016 | 213 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 622 | 0.110 |
Why?
|
| Young Adult | 3 | 2024 | 9925 | 0.100 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 298 | 0.100 |
Why?
|
| Epithelium | 1 | 2014 | 354 | 0.100 |
Why?
|
| Hippocampus | 1 | 2019 | 860 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2014 | 181 | 0.100 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2024 | 75 | 0.100 |
Why?
|
| Rats | 4 | 2024 | 3851 | 0.100 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1692 | 0.100 |
Why?
|
| RNA, Transfer | 1 | 2013 | 77 | 0.100 |
Why?
|
| Software | 2 | 2009 | 732 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2438 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 246 | 0.090 |
Why?
|
| Caveolin 1 | 1 | 2012 | 50 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 782 | 0.090 |
Why?
|
| Child, Preschool | 7 | 2024 | 14865 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2016 | 735 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2014 | 689 | 0.090 |
Why?
|
| Cell Proliferation | 5 | 2019 | 2559 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 460 | 0.090 |
Why?
|
| Amino Acid Motifs | 3 | 2010 | 212 | 0.090 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 148 | 0.090 |
Why?
|
| Neurons | 1 | 2021 | 2050 | 0.090 |
Why?
|
| Mammary Glands, Animal | 1 | 2014 | 479 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2010 | 7 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2015 | 871 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2025 | 249 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 2010 | 57 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 712 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 1463 | 0.080 |
Why?
|
| Protein Domains | 2 | 2023 | 260 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 258 | 0.080 |
Why?
|
| Systems Biology | 1 | 2010 | 63 | 0.080 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2009 | 5 | 0.080 |
Why?
|
| DNA | 1 | 2015 | 1675 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 23 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1049 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 400 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2024 | 5196 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 1757 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2018 | 98 | 0.070 |
Why?
|
| Databases, Genetic | 3 | 2018 | 505 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4823 | 0.070 |
Why?
|
| Data Collection | 1 | 2009 | 395 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 390 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2751 | 0.070 |
Why?
|
| Pancreas | 2 | 2025 | 231 | 0.070 |
Why?
|
| Infant | 5 | 2024 | 13237 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 151 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 318 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 474 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 33 | 0.070 |
Why?
|
| Gene Expression | 3 | 2019 | 1608 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2019 | 1097 | 0.060 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 317 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 614 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 1013 | 0.060 |
Why?
|
| Heterografts | 2 | 2017 | 201 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1730 | 0.060 |
Why?
|
| Recurrence | 2 | 2023 | 1469 | 0.060 |
Why?
|
| Vertebrates | 1 | 2005 | 39 | 0.060 |
Why?
|
| Gene Silencing | 2 | 2019 | 246 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2019 | 3978 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 1405 | 0.050 |
Why?
|
| Protein Binding | 4 | 2010 | 1851 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 1602 | 0.050 |
Why?
|
| Ghrelin | 1 | 2024 | 55 | 0.050 |
Why?
|
| Exons | 3 | 2016 | 825 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2024 | 52 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 65 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 87 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2004 | 299 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2018 | 3131 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 91 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 841 | 0.050 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2024 | 176 | 0.050 |
Why?
|
| Vincristine | 1 | 2024 | 196 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 3046 | 0.050 |
Why?
|
| Pedigree | 2 | 2020 | 1729 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2015 | 316 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 439 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2023 | 182 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 13 | 0.050 |
Why?
|
| Receptors, Cytokine | 1 | 2022 | 67 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2024 | 814 | 0.050 |
Why?
|
| Eating | 1 | 2024 | 393 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 236 | 0.050 |
Why?
|
| Relative Biological Effectiveness | 1 | 2021 | 8 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2021 | 42 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2018 | 787 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2014 | 436 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2021 | 59 | 0.040 |
Why?
|
| Species Specificity | 2 | 2013 | 562 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2003 | 752 | 0.040 |
Why?
|
| Machine Learning | 1 | 2024 | 345 | 0.040 |
Why?
|
| Middle Aged | 4 | 2024 | 28952 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 403 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 126 | 0.040 |
Why?
|
| HIV | 1 | 2022 | 192 | 0.040 |
Why?
|
| Carbon | 1 | 2021 | 98 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2022 | 333 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2003 | 541 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 2 | 2014 | 478 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 236 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 789 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1325 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 35 | 0.040 |
Why?
|
| Phylogeny | 1 | 2022 | 780 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 2 | 2009 | 18 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 351 | 0.040 |
Why?
|
| Aged | 4 | 2024 | 21476 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 780 | 0.040 |
Why?
|
| Rad51 Recombinase | 1 | 2019 | 31 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1849 | 0.040 |
Why?
|
| Gene Drive Technology | 1 | 2019 | 6 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2022 | 400 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2020 | 192 | 0.040 |
Why?
|
| gamma-Globins | 1 | 2018 | 3 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 419 | 0.040 |
Why?
|
| SEER Program | 1 | 2019 | 222 | 0.040 |
Why?
|
| Methylation | 1 | 2019 | 232 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 100 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 141 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2014 | 619 | 0.040 |
Why?
|
| RNA Precursors | 1 | 2018 | 69 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 334 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 326 | 0.040 |
Why?
|
| Adenosine | 1 | 2019 | 139 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 202 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 1340 | 0.030 |
Why?
|
| Cytochromes | 1 | 2017 | 7 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 152 | 0.030 |
Why?
|
| Adult | 4 | 2024 | 31650 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 218 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 730 | 0.030 |
Why?
|
| Chimera | 1 | 2017 | 87 | 0.030 |
Why?
|
| HIV Protease Inhibitors | 1 | 2017 | 47 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 296 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2019 | 254 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3960 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 177 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 439 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 469 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1202 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 7 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 233 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2016 | 19 | 0.030 |
Why?
|
| United States | 2 | 2024 | 11723 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 267 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2019 | 562 | 0.030 |
Why?
|
| Hydrolases | 1 | 2016 | 61 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2016 | 103 | 0.030 |
Why?
|
| Inflammation | 1 | 2024 | 1557 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2015 | 37 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1584 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 17556 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1303 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 572 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3719 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2016 | 245 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 813 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1147 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 829 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 345 | 0.030 |
Why?
|
| Weaning | 1 | 2014 | 51 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 180 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 558 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 20552 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2015 | 372 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 139 | 0.030 |
Why?
|
| Decision Trees | 1 | 2013 | 51 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 2854 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 96 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 108 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 138 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 606 | 0.030 |
Why?
|
| Replication Protein A | 1 | 2013 | 10 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2013 | 144 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 432 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2013 | 90 | 0.030 |
Why?
|
| Argonaute Proteins | 1 | 2013 | 31 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 781 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 579 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3391 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1136 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2012 | 201 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2018 | 1139 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2719 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 713 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2010 | 72 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 825 | 0.020 |
Why?
|
| DNA Probes | 1 | 2009 | 124 | 0.020 |
Why?
|
| DNA Damage | 1 | 2013 | 517 | 0.020 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2009 | 20 | 0.020 |
Why?
|
| Mitosis | 1 | 2010 | 205 | 0.020 |
Why?
|
| Haplorhini | 1 | 2009 | 120 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5436 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2009 | 37 | 0.020 |
Why?
|
| Transcription Factor HES-1 | 1 | 2008 | 19 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 218 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6545 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 542 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 2208 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3418 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3411 | 0.020 |
Why?
|
| DNA Replication | 1 | 2010 | 358 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 672 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 2521 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2785 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 13102 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 687 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 218 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2009 | 363 | 0.020 |
Why?
|
| Systems Integration | 1 | 2007 | 28 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3360 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4577 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 403 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 1280 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 446 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 707 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2006 | 400 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2005 | 120 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 105 | 0.010 |
Why?
|
| Testis | 1 | 2007 | 433 | 0.010 |
Why?
|
| Lung | 1 | 2012 | 1569 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2004 | 33 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 509 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 500 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 1837 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 923 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 786 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 477 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 1041 | 0.010 |
Why?
|